Form D · Other Technology
Fieldstone Bio, Inc.
Andover, MA · CIK 0002052482
Offering snapshot reported Jan 31, 2025 · SEC filing
- Reported sold
- $5.92M Offering amount: $5.92M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 16, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 31, 2025 | Initial | $5,919,997 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-536990
Source: Form D, filed Jan 31, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Calvin Chin | Director |
| Brandon Fields | Director |
| Patrick Stone | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
10 Stevens Street #2036
Andover, MA, 01810
Andover, MA, 01810